MENU
HROW
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Harrow (HROW) Earnings Date & Reports

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U... Show more

A.I. Advisor
published Earnings

HROW is expected to report earnings to rise 40.15% to 46 cents per share on March 25

Harrow HROW Stock Earnings Reports
Q4'25
Est.
$0.46
Q3'25
Beat
by $0.09
Q2'25
Beat
by $0.23
Q1'25
Missed
by $0.56
Q4'24
Beat
by $0.11
The last earnings report on November 10 showed earnings per share of 33 cents, beating the estimate of 23 cents. With 414.50K shares outstanding, the current market capitalization sits at 1.42B.
View a ticker or compare two or three
HROW
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. HROW showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a pharmaceutical company

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
102 Woodmont Boulevard
Phone
+1 615 733-4730
Employees
315
Web
https://www.harrow.com